×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DVAX – dynavax technologies corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DVAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
01:10 pm
dvax
ACTG Announces Publication of BEe-HIVe Trial in JAMA [Yahoo! Finance]
Low
Report
ACTG Announces Publication of BEe-HIVe Trial in JAMA [Yahoo! Finance]
11/26
04:14 pm
dvax
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
Low
Report
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/26
04:05 pm
dvax
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
Low
Report
Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
11/19
10:12 am
dvax
Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial Evaluating its HIV-1 Vaccine [Yahoo! Finance]
Low
Report
Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial Evaluating its HIV-1 Vaccine [Yahoo! Finance]
11/19
09:04 am
dvax
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
Low
Report
Dynavax Technologies Corporation (DVAX): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]
11/11
08:00 am
dvax
Dynavax Announces $100 Million Accelerated Share Repurchase Program
Medium
Report
Dynavax Announces $100 Million Accelerated Share Repurchase Program
11/10
09:17 am
dvax
Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
Medium
Report
Dynavax Technologies Corporation Just Recorded A 9.1% EPS Beat: Here's What Analysts Are Forecasting Next [Yahoo! Finance]
11/8
12:21 pm
dvax
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... [Yahoo! Finance]
Low
Report
Dynavax Technologies Corp (DVAX) Q3 2024 Earnings Call Highlights: Record Hep B Sales and ... [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2024
04:02 pm
dvax
dynavax technologies corporation
BEAT
Report
8.2%
dynavax technologies corporation
8/6/2024
04:01 pm
dvax
dynavax technologies corporation
BEAT
Report
7.0%
dynavax technologies corporation
5/8/2024
04:01 pm
dvax
dynavax technologies corporation
MISS
Report
-5.5%
dynavax technologies corporation
2/22/2024
04:01 pm
dvax
dynavax technologies corporation
BEAT
Report
2.5%
dynavax technologies corporation
Date
Time
Symbol
Headline
Impact
11/14
12:18 pm
dvax
Form SC 13G DYNAVAX TECHNOLOGIES Filed by: Kynam Capital Management, LP
Low
Report
Form SC 13G DYNAVAX TECHNOLOGIES Filed by: Kynam Capital Management, LP
11/12
11:47 am
dvax
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: BlackRock, Inc.
11/12
09:21 am
dvax
Form 8-K DYNAVAX TECHNOLOGIES For: Nov 08
Low
Report
Form 8-K DYNAVAX TECHNOLOGIES For: Nov 08
11/7
04:23 pm
dvax
Form 10-Q DYNAVAX TECHNOLOGIES For: Sep 30
Medium
Report
Form 10-Q DYNAVAX TECHNOLOGIES For: Sep 30
11/7
04:15 pm
dvax
Form 8-K DYNAVAX TECHNOLOGIES For: Nov 07
High
Report
Form 8-K DYNAVAX TECHNOLOGIES For: Nov 07
10/29
04:07 pm
dvax
Form 8-A12B DYNAVAX TECHNOLOGIES
Low
Report
Form 8-A12B DYNAVAX TECHNOLOGIES
10/29
04:06 pm
dvax
Form 8-K DYNAVAX TECHNOLOGIES For: Oct 28
Low
Report
Form 8-K DYNAVAX TECHNOLOGIES For: Oct 28
10/24
04:07 pm
dvax
Form SC 13D/A DYNAVAX TECHNOLOGIES Filed by: Deep Track Capital, LP
Low
Report
Form SC 13D/A DYNAVAX TECHNOLOGIES Filed by: Deep Track Capital, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/7
Form 424B5 DYNAVAX TECHNOLOGIES
21.2%
5/8 Q1/2019 3/31/2019 EPS -0.620 ZacksConsensus -0.670 ActVsEst 0.050 - Beat 17.8%
3/13 Earnings Update: Dynavax Technologies Corporation Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance News] 15.9%
3/16 Form 4 DYNAVAX TECHNOLOGIES For: Mar 13 Filed by: Johnson David Louis 14.0%
8/8 Form 424B5 DYNAVAX TECHNOLOGIES 11.6%
4/28 Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis 7.8%
8/16 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 7.7%
8/13 Form S-8 DYNAVAX TECHNOLOGIES 6.8%
3/19 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.8%
8/12 Form 4 DYNAVAX TECHNOLOGIES For: Aug 12 Filed by: Novack David F 6.4%
5/8 Q1/2019 3/31/2019 EPS -0.620 ZacksConsensus -0.670 ActVsEst 0.050 - Beat 17.8%
3/13 Earnings Update: Dynavax Technologies Corporation Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance News] 15.9%
3/16 Form 4 DYNAVAX TECHNOLOGIES For: Mar 13 Filed by: Johnson David Louis 14.0%
8/8 Form 424B5 DYNAVAX TECHNOLOGIES 11.6%
4/28 Dynavax Reports Interim Analysis of Ongoing Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis 7.8%
8/16 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. 7.7%
8/13 Form S-8 DYNAVAX TECHNOLOGIES 6.8%
3/19 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 6.8%
8/12 Form 4 DYNAVAX TECHNOLOGIES For: Aug 12 Filed by: Novack David F 6.4%
TOP News Decliners
3/11
Q4/2019 12/31/2019 EPS -0.440 ZacksConsensus -0.330 ActVsEst (0.110) - Miss
-22.9%
3/24 Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -19.1%
3/2 Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine -18.2%
5/24 Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at Royal Bank of Canada to $13.00. They now have an "outperform" rating on the stock. -14.0%
7/4 Why Dynavax Technologies' Stock Tanked in June [The Motley Fool] -13.4%
5/11 Dynavax Technologies Co. (NASDAQ: DVAX) had its "outperform" rating re-affirmed by analysts at William Blair. -11.6%
3/12 Form 4 DYNAVAX TECHNOLOGIES For: Mar 11 Filed by: Hack Andrew A. F. -11.1%
7/10 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. -11.1%
4/2 Dynavax Provides Business Update on COVID-19 Pandemic Impact -9.7%
6/4 Form 4 DYNAVAX TECHNOLOGIES For: Jun 02 Filed by: COFFMAN ROBERT -8.8%
3/24 Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -19.1%
3/2 Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine -18.2%
5/24 Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at Royal Bank of Canada to $13.00. They now have an "outperform" rating on the stock. -14.0%
7/4 Why Dynavax Technologies' Stock Tanked in June [The Motley Fool] -13.4%
5/11 Dynavax Technologies Co. (NASDAQ: DVAX) had its "outperform" rating re-affirmed by analysts at William Blair. -11.6%
3/12 Form 4 DYNAVAX TECHNOLOGIES For: Mar 11 Filed by: Hack Andrew A. F. -11.1%
7/10 Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. -11.1%
4/2 Dynavax Provides Business Update on COVID-19 Pandemic Impact -9.7%
6/4 Form 4 DYNAVAX TECHNOLOGIES For: Jun 02 Filed by: COFFMAN ROBERT -8.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: